Jessica Scott
Psychiatric/Mental Health · Lithia Springs, GANPI 1548845795
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 351 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $19.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$698
- Otsuka America Pharmaceutical, Inc.$548
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$520
- Lundbeck LLC$475
- Alkermes, Inc.$453
- plus $3K from 22 others
What the payments were for
- Food & beverage$6,948100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $1,315 |
| Axsome Therapeutics, Inc. | 30 | $698 |
| Otsuka America Pharmaceutical, Inc. | 19 | $548 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $520 |
| Lundbeck LLC | 26 | $475 |
| Alkermes, Inc. | 16 | $453 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $441 |
| Almatica Pharma LLC | 18 | $295 |
| Tris Pharma Inc | 9 | $257 |
| Neos Therapeutics, LP | 19 | $246 |
| Teva Pharmaceuticals USA, Inc. | 13 | $244 |
| Neurocrine Biosciences, Inc. | 4 | $192 |
| Ironshore Pharmaceuticals Inc. | 8 | $161 |
| Johnson & Johnson | 9 | $161 |
| Daiichi Sankyo Inc. | 1 | $144 |
| Corium, LLC | 9 | $140 |
| Idorsia Pharmaceuticals US Inc | 7 | $131 |
| Avanir Pharmaceuticals, Inc. | 6 | $102 |
| Vanda Pharmaceuticals Inc. | 5 | $86 |
| Noven Therapeutics, LLC | 4 | $83 |
| Supernus Pharmaceuticals, Inc. | 3 | $60 |
| Bausch Health US, LLC | 3 | $54 |
| Sunovion Pharmaceuticals Inc. | 2 | $37 |
| Harmony Biosciences LLC | 1 | $32 |
| Collegium Pharmaceutical, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Luye Pharma (USA) Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$448
- Auvelity$233
- Enhertu$144
- ABILIFY ASIMTUFII$122
- ABILIFY MAINTENA$122
- Dyanavel XR$118
- Quillivant$118
- Quillichew ER$118
- REXULTI$111
- INGREZZA$107
How this compares
$6,948 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $478 |
| Bupropion XlBupropion Hcl | 17 | $430 |
| Quetiapine Fumarate | 13 | $399 |
| Clonazepam | 41 | $358 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 30 | $330 |
| Gabapentin | 13 | $292 |
| Escitalopram Oxalate | 25 | $280 |
| Lamotrigine | 19 | $276 |
| Sertraline Hcl | 41 | $274 |
| Fluoxetine Hcl | 26 | $142 |
| Lithium Carbonate | 11 | $106 |
| Trazodone Hcl | 12 | $97 |
| Alprazolam | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $295 | $27441 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Lithia Springs
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.